Chicago, Illinois, October 28, 2009
At the 51st Annual Meeting of the American Society for Radiation
Oncology (ASTRO), November 1 - 5 in Chicago, Illinois, Elekta
will showcase new tools that demonstrate the IGRT-pioneer’s
continued leadership in oncology imaging. Highlights include
Intuity™*and Symmetry™* advanced image-guidance solutions that
build upon the company’s existing expertise.
“We are proud to once again introduce practice-changing
innovations in imaging that demonstrate Elekta’s continued
leadership in IGRT,” says Tomas Puusepp, President and CEO of
Elekta. “Clinicians have long understood that Elekta will
provide them with intelligent tools that enhance their workflow
and patient’s experience and now our collaboration with research
partners has resulted in two new imaging products, Intuity and
Symmetry.”
Intuity, Elekta’s next release of IGRT software, will allow
clinicians to understand continuous changes in the positional
relationships of both tumor and healthy tissues at the time of
treatment. For the first time, this unique innovation will allow
accurate patient repositioning to ensure target coverage without
inadvertently placing organs at risk into the beam path.
Symmetry will be the next generation of image guidance, creating
new solutions for motion management. This unique and patented
innovation will allow clinicians to accurately quantify the
set-up changes required to accommodate ‘baseline shifts’ (tumor
path changes between treatments). Symmetry’s use of anatomically
correlated guidance is an alternative to gating and offers
significantly shorter treatment times with less set-up
complexity.
Other Meeting Highlights
On the show floor, Elekta also plans to highlight innovations
that help clinicians deliver superior cancer care:
- In celebrating
the production of their 2,000th digital linear accelerator,
Elekta will unveil a sixth-generation digital treatment control
system, Integrity™**. Taking advantage of a complete
re-engineering into the LynX OS platform, Integrity adds to its
reputation for efficiency and reliability; MLC interdigitation,
continuously variable dose rate for VMAT and enhanced virus
protection.
- Elekta Infinity,
a premier digital linear accelerator optimized for Volumetric
Modulated Arc Therapy (VMAT). With its unique multi-arcing
capabilities, Infinity delivers unmatched dose conformance,
treatment speed and ultra-low dose safeguards and is the only
fully integrated treatment system that allows personalization of
imaging and treatment workflows.
- MOSAIQ® 2.0 , a
comprehensive oncology charting solution that increases
productivity, elevates efficiency and facilitates high-quality
patient care. Complete with new connectivity, new functions and
database enhancements, while preserving the user interface,
MOSAIQ supports the entire cancer team by uniting diverse
systems and devices.
- Monaco® with
VMAT, a next generation IMRT treatment planning system that
helps make the planning process easier, more straightforward and
clinically reliable. With reduced planning time and increased
clinical throughput, Monaco with VMAT optimizes single or
multiple non-coplanar arcs simultaneously, providing the
flexibility and control needed for complex treatment plans.
- Extend™, a new
stereotactic treatment program that lets neurosurgeons and
radiation oncologists apply the power and precision of Gamma
Knife® surgery to a broader class of targets in the head and
neck. Now available in the United States, Extend for Leksell
Gamma Knife® Perfexion™ includes a re-locatable frame and
support for fractionated treatments, which provides cross
functional advantages in SRS and SRT for neurosurgeons and
radiation oncologists.
A complete
product preview also will be provided to Elekta, Impac and CMS
customers Saturday, October 31 at the Radiation Oncology Users
Meeting (ROUM). Now in its 18th year, the ROUM will cover topics
such as the latest technology and treatment techniques for
cancer care, government stimulus and changes in reimbursement.
“Everyone attending ASTRO and the ROUM will recognize how the
Elekta Group, including Impac and CMS Software, has moved
forward with a shared vision to deliver advances that help
patients live longer, better lives,” says Jay Hoey, President
and CEO of Elekta North America. ”In addition, customers will
see how this shared vision is evolving into intelligent
solutions they can easily integrate into their clinics.”
Events held in conjunction with ASTRO
In addition to the Users Meeting, Elekta plans to host the
following events:
- Daily
clinical presentations, Sunday, November 1 – Tuesday,
November 3 at Elekta booth 2501. For a complete speaker
schedule, visit
www.elekta.com/astro_presentations
- Halloween
Charity Bash, Saturday, October 31 from 7:30 - 11:30 p.m. at
Union Station Chicago, 225 South Canal Street. For
additional information, visit
www.elekta.com/astroevents
- Investor
Meeting, Tuesday, November 2 from noon - 2 p.m. at the
Hilton Hotel, Marquette Room, 720 South Michigan Avenue
*Intuity and
Symmetry are feature sets of XVI 4.5, works in progress
requiring a 510(k) review and not yet available in the U.S.
**Integrity is a works in progress requiring 510(k) review and
not yet available in the U.S.
About Elekta
Elekta
is a human care company pioneering significant innovations and
clinical solutions for treating cancer and brain disorders. The
company develops sophisticated, state-of-the-art tools and
treatment planning systems for radiation therapy and
radiosurgery, as well as workflow enhancing software systems
across the spectrum of cancer care.
Stretching the boundaries of science and technology, providing
intelligent and resource-efficient solutions that offer
confidence to both healthcare providers and patients, Elekta
aims to improve, prolong and even save patient lives, making the
future possible today.
Today, Elekta solutions in oncology and neurosurgery are used in
over 5,000 hospitals globally, and every day more than 100,000
patients receive diagnosis, treatment or follow-up with the help
of a solution from the Elekta Group.
Elekta employs around 2,500 employees globally. The corporate
headquarter is located in Stockholm, Sweden, and the company is
listed on the Nordic Exchange under the ticker EKTAb. For more
information about Elekta, please visit
www.elekta.com. |
